Product
R-(-)-Gossypol
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Phase I/II Trial of AT-101 in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed Symptomatic Multiple MyelomaStatus: Completed, Estimated PCD: 2018-10-26